165 related articles for article (PubMed ID: 22074422)
21. Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).
Zadrazilova I; Pospisilova S; Masarikova M; Imramovsky A; Ferriz JM; Vinsova J; Cizek A; Jampilek J
Eur J Pharm Sci; 2015 Sep; 77():197-207. PubMed ID: 26079401
[TBL] [Abstract][Full Text] [Related]
22. [Salicylanilides: still a potential antibacterially active group].
Vinsová J; Imramovský A
Ceska Slov Farm; 2004 Nov; 53(6):294-9. PubMed ID: 15630995
[TBL] [Abstract][Full Text] [Related]
23. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains.
Imramovský A; Vinsová J; Férriz JM; Dolezal R; Jampílek J; Kaustová J; Kunc F
Bioorg Med Chem; 2009 May; 17(10):3572-9. PubMed ID: 19403314
[TBL] [Abstract][Full Text] [Related]
24. Application of reactive salicylanilide to viscose fabrics as antibacterial and antifungus finishing.
El-Sayed AA; Dorgham SM; Kantouch A
Int J Biol Macromol; 2012 Jan; 50(1):273-6. PubMed ID: 22115716
[TBL] [Abstract][Full Text] [Related]
25. Investigating the spectrum of biological activity of ring-substituted salicylanilides and carbamoylphenylcarbamates.
Otevrel J; Mandelova Z; Pesko M; Guo J; Kralova K; Sersen F; Vejsova M; Kalinowski DS; Kovacevic Z; Coffey A; Csollei J; Richardson DR; Jampilek J
Molecules; 2010 Nov; 15(11):8122-42. PubMed ID: 21072023
[TBL] [Abstract][Full Text] [Related]
26. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
[TBL] [Abstract][Full Text] [Related]
27. New Caffeic Acid Derivatives as Antimicrobial Agents: Design, Synthesis, Evaluation and Docking.
Merlani M; Barbakadze V; Amiranashvili L; Gogilashvili L; Poroikov V; Petrou A; Geronikaki A; Ciric A; Glamoclija J; Sokovic M
Curr Top Med Chem; 2019; 19(4):292-304. PubMed ID: 30674263
[TBL] [Abstract][Full Text] [Related]
28. Antimycobacterial and antifungal isosters of salicylamides.
Waisser K; Pesina M; Holý P; Pour M; Bures O; Kunes J; Klimesová V; Buchta V; Kubanová P; Kaustová J
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):322-35. PubMed ID: 12953220
[TBL] [Abstract][Full Text] [Related]
29. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
30. Affinity-Based Screen for Inhibitors of Bacterial Transglycosylase.
Wu WS; Cheng WC; Cheng TR; Wong CH
J Am Chem Soc; 2018 Feb; 140(8):2752-2755. PubMed ID: 29411975
[TBL] [Abstract][Full Text] [Related]
31. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
[TBL] [Abstract][Full Text] [Related]
32. Efficient Synthesis and Biological Evaluation of a Novel Series of 1,5-Benzodiazepine Derivatives as Potential Antimicrobial Agents.
An YS; Hao ZF; Zhang XJ; Wang LZ
Chem Biol Drug Des; 2016 Jul; 88(1):110-21. PubMed ID: 26850700
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Bioactivity Evaluation, and Toxicity Assessment of Novel Salicylanilide Ester Derivatives as Cercaricides against Schistosoma japonicum and Molluscicides against Oncomelania hupensis.
Wang W; Qin Z; Zhu D; Wei Y; Li S; Duan L
Antimicrob Agents Chemother; 2016 Jan; 60(1):323-31. PubMed ID: 26503661
[TBL] [Abstract][Full Text] [Related]
34. In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
Baranyai Z; Krátký M; Vosátka R; Szabó E; Senoner Z; Dávid S; Stolaříková J; Vinšová J; Bősze S
Eur J Med Chem; 2017 Jun; 133():152-173. PubMed ID: 28384546
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial Activity of New 2-Thioxo-benzo[g]quinazolin-4(3H)-one Derivatives.
Al-Salahi R; Abuelizz HA; Dib RE; Marzouk M; Alshammari MB
Med Chem; 2016; 13(1):85-92. PubMed ID: 27306606
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents.
Tandon VK; Yadav DB; Maurya HK; Chaturvedi AK; Shukla PK
Bioorg Med Chem; 2006 Sep; 14(17):6120-6. PubMed ID: 16806945
[TBL] [Abstract][Full Text] [Related]
37. Antiviral activity of substituted salicylanilides--a review.
Krátký M; Vinšová J
Mini Rev Med Chem; 2011 Oct; 11(11):956-67. PubMed ID: 21762100
[TBL] [Abstract][Full Text] [Related]
38. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
39. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
Tandon VK; Yadav DB; Singh RV; Chaturvedi AK; Shukla PK
Bioorg Med Chem Lett; 2005 Dec; 15(23):5324-8. PubMed ID: 16202590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
